ADVERTISEMENT
News
Class I Recall Issued for Anticonvulsant
03/04/2020
The recall affects phenytoin oral suspension, 125 mg/5 mL potency, 8 fluid ounces (237 mL; NDC 51672-4069-1) from lots 327874 and 327876 (Exp. 12/20). The bottles were distributed throughout the United States.
Taro Pharmaceuticals voluntarily initiated the recall February 7, 2020. The FDA issued the Class I designation March 2, 2020.
Phenytoin oral suspension is a prescription anticonvulsant used to prevent and control seizures.
—Jolynn Tumolo